CTSO
Cytosorbents Crp
4.10$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.0% | 49.6% | 48.3% | 48.7% | 44.0% | 29.4% | 35.4% | 34.0% | 40.2% | 38.1% | 38.0% | 31.4% | 29.6% | 31.7% | 29.2% | 34.1% | 28.2% | 21.1% | 27.1% | 23.8% | 27.7% | 25.8% | 28.7% | 41.8% | 69.5% | 38.7% | 42.3% | 36.1% | 41.3% | 31.9% | 23.5% | 26.5% | 47.7% | -2.7% | 28.9% | 29.1% | 29.7% | 26.3% | 30.8% | 26.8% | 28.4% | |
| 55.0% | 50.4% | 51.7% | 51.3% | 56.0% | 70.6% | 64.7% | 66.0% | 59.8% | 61.9% | 62.0% | 68.6% | 70.4% | 68.3% | 70.8% | 65.9% | 71.8% | 78.9% | 72.9% | 76.2% | 72.3% | 74.2% | 71.3% | 58.2% | 30.5% | 61.3% | 57.7% | 63.9% | 58.7% | 68.1% | 76.5% | 73.5% | 52.3% | 102.7% | 71.1% | 70.9% | 70.3% | 73.7% | 69.2% | 73.2% | 71.6% | |
| 54.7% | 63.6% | 18.1% | 16.0% | 15.6% | 56.4% | 40.2% | 30.0% | 38.1% | 44.3% | 52.9% | 50.1% | 55.6% | 53.8% | 24.1% | 25.3% | 17.1% | 22.5% | 22.5% | 32.5% | 47.9% | 56.9% | 53.5% | 49.2% | 50.9% | 36.2% | 44.6% | 38.9% | 48.4% | 55.7% | 25.0% | 17.2% | 21.5% | 14.2% | 19.1% | 13.1% | 9.7% | 13.5% | 11.6% | 15.1% | 12.5% | |
| 112.9% | 179.6% | 113.5% | 129.2% | 110.6% | 110.9% | 105.5% | 125.5% | 87.3% | 130.9% | 116.2% | 87.2% | 119.4% | 109.1% | 83.8% | 78.1% | 76.7% | 9.2% | 83.0% | 92.7% | 94.8% | 5.9% | 125.7% | 6.5% | 144.6% | 5.9% | 7.1% | 12.4% | 118.7% | 143.7% | 102.9% | 95.0% | 90.9% | 22.0% | 96.6% | 95.3% | 90.8% | 102.2% | 91.9% | 82.7% | 91.8% | |
| 155.1% | 225.3% | 111.7% | 130.6% | 122.3% | 159.1% | 136.3% | 145.8% | 112.9% | 164.0% | 155.6% | 130.7% | 168.6% | 150.5% | 101.2% | 100.5% | 90.9% | 100.9% | 101.0% | 119.5% | 133.1% | 162.9% | 169.6% | 156.6% | 170.0% | 129.0% | 141.2% | 133.5% | 153.5% | 199.3% | 128.3% | 113.9% | 103.3% | 146.9% | 115.7% | 108.4% | 100.5% | 115.6% | 103.5% | 100.6% | 105.0% | |
| -100.0% | -174.9% | -60.0% | -76.7% | -62.3% | -88.6% | -70.0% | -79.8% | -53.1% | -102.1% | -93.6% | -62.1% | -98.3% | -82.2% | -30.4% | -34.6% | -19.1% | -22.0% | -28.1% | -43.3% | -60.7% | -88.7% | -98.3% | -98.4% | -139.5% | -67.7% | -83.5% | -69.6% | -94.8% | -131.2% | -51.8% | -40.4% | -51.0% | -44.2% | -44.5% | -37.6% | -30.2% | -42.0% | -34.3% | -27.4% | -33.4% | |
| 5.5% | 4.6% | 4.6% | 4.1% | 7.4% | 5.9% | 5.4% | 16.0% | 3.6% | 3.6% | 4.5% | 3.7% | 5.3% | 4.7% | 3.8% | 2.9% | 2.5% | 3.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.3% | 0.7% | 0.6% | 0.7% | 0.1% | 0.4% | 0.7% | 0.1% | 2.0% | 6.8% | 6.8% | 6.9% | 6.4% | 6.8% | 8.1% | 9.7% | 9.0% | 8.4% | |
| -125.2% | -181.1% | -58.7% | -36.7% | -59.6% | -89.0% | -67.3% | -111.0% | -58.9% | -110.1% | -106.7% | -60.6% | -120.2% | -76.3% | -42.3% | -30.1% | -8.2% | -15.1% | -41.1% | -41.2% | -72.0% | -93.1% | -113.1% | -128.1% | -188.8% | -19.8% | -77.5% | -65.3% | -118.6% | -94.6% | -67.7% | -48.6% | -27.1% | -104.6% | -16.9% | 20.2% | -37.6% | -59.5% | -57.9% | -45.9% | -50.0% | |
| 25.1% | -12.2% | -6.9% | -40.0% | -2.7% | -15.8% | -2.7% | 31.1% | 5.8% | -11.3% | 13.1% | -1.4% | 22.0% | -16.5% | 11.9% | -4.5% | -10.9% | -9.4% | 13.0% | -0.1% | -0.1% | -6.8% | -0.1% | 29.4% | -0.7% | -11.6% | -6.0% | -4.3% | -5.5% | -11.1% | 0.0% | 0.0% | – | -18.5% | – | – | -4.2% | – | – | – | – | |
| -125.2% | -145.9% | -53.1% | -36.7% | -59.6% | -73.3% | -67.3% | -111.0% | -58.9% | -98.8% | -106.7% | -60.6% | -120.2% | -59.7% | -42.3% | -30.1% | -8.2% | -5.7% | -41.1% | -41.2% | -72.0% | -86.3% | -113.1% | -128.1% | -188.8% | -8.2% | -77.5% | -65.3% | -118.6% | -83.5% | -67.7% | -48.6% | -27.1% | -86.2% | -16.9% | 20.2% | -33.4% | -59.5% | -57.9% | -45.9% | -48.9% | |
| -94.8% | -172.9% | -51.7% | -51.7% | -50.5% | -115.7% | -68.7% | -93.8% | -52.5% | -104.0% | -99.2% | -54.6% | -112.5% | -69.0% | -36.4% | -25.6% | -4.1% | -20.6% | -39.4% | -40.1% | -69.3% | -83.5% | -109.6% | -94.2% | -184.5% | -63.1% | -74.1% | -65.1% | -112.2% | -83.1% | -62.7% | -41.5% | -15.3% | -93.2% | -5.4% | 31.2% | -26.6% | -47.3% | -44.0% | -34.8% | -38.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.